areteiatx.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: *
Meta Tags
Title Areteia Therapeutics -
Description Pioneering a new era in asthma Areteia Therapeutics is a new biotechnology company committed to putting asthma patients in better control of their disease—and back in control of their lives—with the first potential oral drug for eosinophilic
Keywords N/A
Server Information
WebSite areteiatx faviconareteiatx.com
Host IP 104.26.0.205
Location United States
Related Websites
Site Rank
More to Explore
areteiatx.com Valuation
US$1,470
Last updated: 2023-05-18 18:58:09

areteiatx.com has Semrush global rank of 0. areteiatx.com has an estimated worth of US$ 1,470, based on its estimated Ads revenue. areteiatx.com receives approximately 169 unique visitors each day. Its web server is located in United States, with IP address 104.26.0.205. According to SiteAdvisor, areteiatx.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,470
Daily Ads Revenue US$1
Monthly Ads Revenue US$40
Yearly Ads Revenue US$488
Daily Unique Visitors 11
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
areteiatx.com. A 300 IP: 104.26.0.205
areteiatx.com. A 300 IP: 172.67.74.91
areteiatx.com. A 300 IP: 104.26.1.205
areteiatx.com. AAAA 300 IPV6: 2a06:98c1:3122:a000::
areteiatx.com. NS 86400 NS Record: athena.ns.cloudflare.com.
areteiatx.com. NS 86400 NS Record: vasilii.ns.cloudflare.com.
areteiatx.com. MX 3600 MX Record: 10 mx1-us1.ppe-hosted.com.
areteiatx.com. MX 3600 MX Record: 20 mx2-us1.ppe-hosted.com.
areteiatx.com. TXT 300 TXT Record: ppe-85b98ba515c7a8b2eb891c11e36b85904ec0ede6
areteiatx.com. TXT 300 TXT Record: MS=ms40902238
areteiatx.com. TXT 300 TXT Record: v=spf1 a:dispatch-us.ppe-hosted.com include:spf.protection.outlook.com ip4:147.160.167.0/26 include:_spf.psm.knowbe4.com ~all
areteiatx.com. TXT 300 TXT Record: google-site-verification=ySr6AUkOHXp7NAYIuLFpcajnq9g3mfRUlTaip_hvu6U
HtmlToTextCheckTime:2023-05-18 18:58:09
= 50 ? scrolledFromTop = true : scrolledFromTop = false; st = window.pageYOffset || document.documentElement.scrollTop; if (st > lastScrollTop && window.pageYOffset >= 50 && !mobileMenuOpen) { console.log(’scroll down event! past pageYOffset 50! ’ + scrolledFromTop); showNav = false; } else {showNav = true;} lastScrollTop = st <= 0 ? 0 : st;" x-show="showNav" x-transition:enter="transition ease-linear duration-300" x-transition:enter-start="transform -translate-y-40" x-transition:enter-end="transform translate-y-0" x-transition:leave="transition ease-linear duration-300" x-transition:leave-start="transform translate-y-0" x-transition:leave-end="transform -translate-y-40" x-cloak @keydown.escape="mobileMenuOpen = false" > Home Pioneering a New Era In Asthma Control Our Advanced Candidate: Dexpramipexole Who We Are About Us Eosinophilic Asthma Our Science A New Approach How Did We Get Here? Phase 3 Development Program News News Releases Publications Presentations Contact
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Fri, 15 Jul 2022 08:42:09 GMT
Connection: keep-alive
Cache-Control: max-age=3600
Expires: Fri, 15 Jul 2022 09:42:09 GMT
Location: https://areteiatx.com/
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=zuXTYFFsZSMRaaduMHNhEk6QZQ90fTUp1nnZ%2FNZ1uykhNe3lUt9KfvuizpMWccCSCHnzYImFe5DpT43t2ehYxIBLxR6900E7UWN1CNNZPg70HE8mfDZEzssoSwv1UC8kySMK3eabK6YbqWA%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 72b134032a814995-DME

HTTP/2 200 
date: Fri, 15 Jul 2022 08:42:10 GMT
content-type: text/html; charset=UTF-8
x-powered-by: PHP/8.1.7
cache-control: no-cache, private
set-cookie: XSRF-TOKEN=eyJpdiI6IlliRFJPYnBCT1dWZ0lqdTNVWkVBT3c9PSIsInZhbHVlIjoiYmhJbm9CWUZEa2NKMFhUZGZWdGlZWXJvN0xnSEJHQUZYRStFdWs2TEZmdDJVVmRodVE1TExQV2JReXhuVkljdllSa3ZtRXhpL3hCOW16d1gzMm9acXVCMHhNSGI3TnNYdVNTTG9Lb0tUNkQzNHdvc3FnNzdCOS9UanRkWkpIOEYiLCJtYWMiOiJjODhmZmNmMDg4Nzg4Y2Q1Y2FkYzM2NTlkYTE0NTg5MjAyMDRlZmJhNzlkYmI2MzM5YzU3OGJiYzAyZGVkZmZiIiwidGFnIjoiIn0%3D; expires=Fri, 15 Jul 2022 10:42:10 GMT; Max-Age=7200; path=/; samesite=lax
set-cookie: areteia_session=eyJpdiI6ImJYanRGTWlwc0tMS0RkVFlQTTgxNUE9PSIsInZhbHVlIjoiSUVDRHlxbHl3ZURadFIrSFZqdzZJRzRUQWN1VUNzR09yV0tIdk51c21GeG1yTndWUXhNelEvU1NpZFpaR3hjRDdOWUZlWmMybVY4aXZ0VmErNnB4OURHVDY0RXNtUmcrZWJaY0dveTRJZmZhR25VS2pJZnBSTExRaU9JeUc5Z3MiLCJtYWMiOiIxZTBmZjEzMzBmMmY2MGJkMjg5OGYyZjVmYjE5MDU0N2QyM2U5NmY3M2RlZGRhYTgwZDI5NWM0M2MwNTkwZGQyIiwidGFnIjoiIn0%3D; expires=Fri, 15 Jul 2022 10:42:10 GMT; Max-Age=7200; path=/; httponly; samesite=lax
vary: Accept-Encoding
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=oKUanArmJFMJbLO2Sn2U45xbqTmRisg%2FOwnaVsoqc7Kol4Bs6jztZSHKEjYDDUGl3jiTEgcmOz6pjk5NIGVchdY%2FojCZ8owcgEahvF8cBbfkTLJdrSbXRzRkrUTLghPtDiwAfwyVT1LjSFg%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 72b13403d8139d99-DME
areteiatx.com Whois Information
Domain Name: ARETEIATX.COM
Registry Domain ID: 2687749234_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2022-06-14T04:28:39Z
Creation Date: 2022-04-08T15:36:33Z
Registry Expiry Date: 2024-04-08T15:36:33Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: ATHENA.NS.CLOUDFLARE.COM
Name Server: VASILII.NS.CLOUDFLARE.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-07-15T08:39:22Z <<<